Nasdaq · Common Stock · Surgical & Medical Instruments & Apparatus
insulin delivery device company
22 entities across 16 jurisdictions. Read directly from the company’s own 10-K EX-21 filed 2026-02-18 — see the exhibit.
Which other public companies file entities in the same places:
| Entity | Jurisdiction | Note |
|---|---|---|
| Insulet Asia (Singapore) Pte. Ltd. | Singapore | |
| Insulet Austria GmbH | Austria | |
| Insulet Australia Pty Ltd | Australia | |
| Insulet Canada Corporation | Canada | |
| Insulet Consulting (Shenzhen) Co., Ltd. | China | |
| Insulet France SAS | France | |
| Insulet Germany GmbH | Germany | |
| Insulet Guadalajara, S. de R.L. de C.V. | Mexico | |
| Insulet International Holdings Ltd. | United Kingdom | |
| Insulet International Ltd. | United Kingdom | |
| Insulet MA Securities Corporation | Massachusetts | |
| Insulet Malaysia Sdn. Bhd. | Malaysia | |
| Insulet Mexico Investments LLC | Delaware | |
| Insulet Mexico, S. de R.L. de C.V. | Mexico | |
| Insulet Netherlands B.V. | Netherlands | |
| Insulet Netherlands Holdings B.V. | Netherlands | |
| Insulet Portugal, Unipessoal Lda | Portugal | |
| Insulet Realty Holdings LLC | Delaware | |
| Insulet Singapore Private Limited | Singapore | |
| Insulet Spain S.L. | Spain | |
| Insulet Switzerland GmbH | Switzerland | |
| Sub-Q Solutions, Inc. | Delaware |
Two standard screens, computed from the XBRL in FY2025 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.
Bankruptcy-risk screen combining working capital, retained earnings, operating income, market value against liabilities, and asset turnover. Above 2.99 is the safe zone; below 1.81 is distress.
| Year | Revenue | Net income | Free cash flow | Gross margin | Shares |
|---|---|---|---|---|---|
| FY2020 | $904.4M | $6.8M | −$45.0M | 64.4% | 65,946,000 |
| FY2021 | $1.1B | $16.8M | −$180.0M | 68.4% | 68,579,000 |
| FY2022 | $1.3B | $4.6M | −$3.9M | 61.7% | 69,910,000 |
| FY2023 | $1.7B | $206.3M | $70.1M | 68.3% | 73,633,000 |
| FY2024 | $2.1B | $418.3M | $305.4M | 69.8% | 73,890,000 |
| FY2025 | $2.7B | $247.1M | $377.7M | 71.6% | 71,886,000 |
17 institutions tracked — 11 added, 5 reduced, 1 opened a new position. Index money added 447,513 shares while active managers cut 1,112,848.
| Manager | Kind | Shares | Change | Value |
|---|---|---|---|---|
| FMR LLC | Active fund | 964,297 | −3,010,415 | $146.8M |
| AQR CAPITAL MANAGEMENT LLC | Hedge fund | 2,455,135 | +856,411 | $373.8M |
| CITADEL ADVISORS LLC | Hedge fund | 861,746 | +603,307 | $131.2M |
| MORGAN STANLEY | Active fund | 1,479,050 | +333,119 | $225.2M |
| BlackRock, Inc. | Index | 6,690,192 | +314,249 | $1.0B |
| JPMORGAN CHASE & CO | Active fund | 595,123 | +307,970 | $94.4M |
| RENAISSANCE TECHNOLOGIES LLC | Hedge fund | 202,083 | −223,920 | $30.8M |
| STATE STREET CORP | Index | 3,197,555 | +155,101 | $486.8M |
| Bridgewater Associates, LP | Hedge fund | 156,413 | +121,077 | $23.8M |
| WELLINGTON MANAGEMENT GROUP LLP | Active fund | 16,744 | −91,010 | $2.5M |
| PRICE T ROWE ASSOCIATES INC /MD/ | Active fund | 214,349 | −68,288 | $32.6M |
| BANK OF AMERICA CORP /DE/ | Active fund | 426,409 | +30,369 | $64.9M |
| GEODE CAPITAL MANAGEMENT, LLC | Index | 2,003,861 | −21,837 | $304.0M |
| BAILLIE GIFFORD & CO | Value | 2,042,313 | +12,821 | $310.9M |
| Point72 Asset Management, L.P. | Hedge fund | 14,200 | +11,000 | $2.2M |
| Capital World Investors | Active fund | 172,712 | +4,711 | $26.3M |
NORGES BANK holds a position with no prior filing to compare against, so its change is unknown rather than zero — and it is left out of the totals above.
From 13F filings, which cover institutions managing over $100m and are filed up to 45 days after the quarter ends — so this is a considered position, not a live one, and it is not the whole shareholder register.
What the company actually paid out and bought back, as reported — the record behind any yield figure.
Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.
INSULET CORP files under SIC 3841 — all 38 surgical & medical instruments & apparatus companies compared on assets and F-score.
The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.
Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.
